The global Cyazofamid market size is predicted to grow from US$ 114 million in 2025 to US$ 127 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
LP Information, Inc. (LPI) ' newest research report, the “Cyazofamid Industry Forecast” looks at past sales and reviews total world Cyazofamid sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyazofamid sales for 2025 through 2031. With Cyazofamid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyazofamid industry.
This Insight Report provides a comprehensive analysis of the global Cyazofamid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyazofamid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyazofamid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyazofamid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyazofamid.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyazofamid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Agriculture Grade
Others
Segmentation by Application:
Downy Mildew
Oomycetes Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cyazofamid market?
What factors are driving Cyazofamid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyazofamid market opportunities vary by end market size?
How does Cyazofamid break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook